These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10914727)

  • 1. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.
    Cascinu S; Staccioli MP; Gasparini G; Giordani P; Catalano V; Ghiselli R; Rossi C; Baldelli AM; Graziano F; Saba V; Muretto P; Catalano G
    Clin Cancer Res; 2000 Jul; 6(7):2803-7. PubMed ID: 10914727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
    Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-phase fraction can predict event free survival in patients with pT2-T3N0M0 colorectal carcinoma: implications for adjuvant chemotherapy.
    Cascinu S; Ligi M; Graziano F; Del Ferro E; Valentini M; Grianti C; Bartolucci M; Catalano G
    Cancer; 1998 Sep; 83(6):1081-5. PubMed ID: 9740071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
    Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
    Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.
    Chin KF; Greenman J; Gardiner E; Kumar H; Topping K; Monson J
    Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer.
    Lennard CM; Patel A; Wilson J; Reinhardt B; Tuman C; Fenton C; Blair E; Francis GL; Tuttle RM
    Surgery; 2001 May; 129(5):552-8. PubMed ID: 11331447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor in primary superficial bladder cancer.
    Chow NH; Liu HS; Chan SH; Cheng HL; Tzai TS
    Anticancer Res; 1999; 19(5C):4593-7. PubMed ID: 10650816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K; Christensen IJ; Brünner N; Nielsen HJ
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas.
    Hida Y; Morita T; Fujita M; Miyasaka Y; Horita S; Fujioka Y; Nagashima K; Katoh H
    Anticancer Res; 1999; 19(3B):2257-60. PubMed ID: 10472340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosol vascular endothelial growth factor in endometrial carcinoma: correlation with disease-free survival.
    Chen CA; Cheng WF; Lee CN; Wei LH; Chu JS; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 2001 Feb; 80(2):207-12. PubMed ID: 11161861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
    Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.
    Wu Y; Saldana L; Chillar R; Vadgama JV
    Int J Oncol; 2002 Mar; 20(3):509-16. PubMed ID: 11836562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
    Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J
    Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
    Linderholm B; Tavelin B; Grankvist K; Henriksson R
    Br J Cancer; 1999 Oct; 81(4):727-32. PubMed ID: 10574263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
    Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
    Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
    Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis.
    Khorana AA; Ryan CK; Cox C; Eberly S; Sahasrabudhe DM
    Cancer; 2003 Feb; 97(4):960-8. PubMed ID: 12569594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.